Bromide

Bromide

SCHEMBL931587

Br.O=C(CBr)c1ccc(OCCCCl)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 8/20 0.56
L3MBTL1 Q9Y468 2/20 0.50
PTPN1 P18031 5/20 0.48
MAPT P10636 2/20 0.47
GAA P10253 1/20 0.47
NPC1 O15118 1/20 0.45
THRA P10827 1/20 0.44
THRB P10828 1/20 0.44
MMP1 P03956 1/20 0.44
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1373155 0.98 GSK3B (0.58) GSK3BL3MBTL1PTPN1MAPTGAA
SCHEMBL11728169 0.91 GSK3B (0.58) GSK3BL3MBTL1PTPN1MAPTGAA
SCHEMBL15018952 0.84 GSK3B (0.58) GSK3BL3MBTL1PTPN1MAPTGAA
SCHEMBL5055145 0.84 L3MBTL1 (0.65) GSK3BL3MBTL1MAPTNPC1THRA
SCHEMBL9786122 0.82 GSK3B (0.59) GSK3BL3MBTL1PTPN1MAPTGAA
SCHEMBL2356907 0.81 TP53 (0.66) GSK3BL3MBTL1THRATHRBMMP1
SCHEMBL28685529 0.81 GSK3B (0.58) GSK3BL3MBTL1MAPTGAANPC1
SCHEMBL5057170 0.81 L3MBTL1 (0.70) GSK3BL3MBTL1PTPN1MAPTNPC1
SCHEMBL5745992 0.81 GSK3B (0.58) GSK3BL3MBTL1PTPN1MAPTGAA
SCHEMBL6640853 0.81 L3MBTL1 (0.60) L3MBTL1MAPTGAANPC1MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2459529-A1 SUBSTITUTED PHENOXYPROPYLCYCLOAMINE DERIVATIVES AS HISTAMINE-3 (H3) RECEPTOR LIGANDS Cephalon, Inc. (US) 2012-06-06 EP disclosed
WO-2011002984-A1 SUBSTITUTED PHENOXYPROPYLCYCLOAMINE DERIVATIVES AS HISTAMINE-3 (H3) RECEPTOR LIGANDS CEPHALON, INC. (US) 2011-01-06 WO disclosed